Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endometrial cancer
Emma J. Crosbie, Sarah Kitson, Jessica N. McAlpine, et al.
The Lancet (2022) Vol. 399, Iss. 10333, pp. 1412-1428
Open Access | Times Cited: 759

Showing 1-25 of 759 citing articles:

The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 408
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program

International Journal of Gynecological Cancer (2022) Vol. 33, Iss. 1, pp. 109-117
Open Access | Times Cited: 108
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 93
Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment
Holly Baker‐Rand, Sarah Kitson
Cancers (2024) Vol. 16, Iss. 5, pp. 1028-1028
Open Access | Times Cited: 22
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes
Ilaria Cuccu, Francesco Raspagliesi, Mario Malzoni, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 4, pp. 108018-108018
Closed Access | Times Cited: 20
Prediction of recurrence risk in endometrial cancer with multimodal deep learning
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1962-1973
Open Access | Times Cited: 19
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision
G Zaffaroni, Alessandro Mannucci, Laura Koskenvuo, et al.
British journal of surgery (2024) Vol. 111, Iss. 5
Open Access | Times Cited: 18
FIGO 2023 staging system predicts not only survival outcome but also recurrence pattern in corpus-confined endometrial cancer patients
Hua-Hsi Wu, Hung-Tse Chou, Shih-Yao Lin, et al.
Taiwanese Journal of Obstetrics and Gynecology (2025) Vol. 64, Iss. 1, pp. 76-81
Open Access | Times Cited: 3
Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for Early-Stage Endometrial and Cervical Cancers
Mihan Lee, Pamela Causa Andrieu, Stéphanie Nougaret, et al.
American Journal of Roentgenology (2025), pp. 1-16
Closed Access | Times Cited: 2
Cost-effectiveness analysis of durvalumab with chemotherapy and maintenance durvalumab with or without olaparib for advanced endometrial cancer
Jiahao Zhang, Jianying Lei, Caicong You, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Endometrial cancer: Part I. Basic concept
Peng‐Hui Wang, Szu‐Ting Yang, Chia-Hao Liu, et al.
Taiwanese Journal of Obstetrics and Gynecology (2022) Vol. 61, Iss. 6, pp. 951-959
Closed Access | Times Cited: 42
Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis
Junde Zhao, Jiani Zou, Wenjian Jiao, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 41
Fertility-Sparing Strategies for Early-Stage Endometrial Cancer: Stepping towards Precision Medicine Based on the Molecular Fingerprint
Giuseppe Gullo, Gaspare Cucinella, Vito Chiàntera, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 811-811
Open Access | Times Cited: 37
Minimally invasive approaches for the early detection of endometrial cancer
Yufei Shen, Wenqing Yang, Jiachen Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 36
Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists
Wenxin Zheng
Cancers (2023) Vol. 15, Iss. 16, pp. 4101-4101
Open Access | Times Cited: 32
Dietary Factors and Endometrial Cancer Risk: A Mendelian Randomization Study
Xue Min Wang, Dylan M. Glubb, Tracy A. O’Mara
Nutrients (2023) Vol. 15, Iss. 3, pp. 603-603
Open Access | Times Cited: 31
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
Sandro Pignata, Giovanni Scambia, Clorinda Schettino, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 3, pp. 286-296
Closed Access | Times Cited: 29
An integrated approach of network pharmacology, molecular docking, and experimental verification uncovers kaempferol as the effective modulator of HSD17B1 for treatment of endometrial cancer
Guanyu Ruan, Lixiang Ye, Jian-Song Lin, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer
Calen Kucera, Chunqiao Tian, Christopher M. Tarney, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e238437-e238437
Open Access | Times Cited: 29
Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer
Zahra Raisi‐Estabragh, Jackie A. Cooper, Celeste McCracken, et al.
Heart (2023) Vol. 109, Iss. 13, pp. 1007-1015
Open Access | Times Cited: 27
Targeting IGF2BP3 in Cancer
Xin Liu, Jiayu Chen, Wenliang Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9423-9423
Open Access | Times Cited: 27
Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer
Sushmita Gordhandas, William A. Zammarrelli, Eric Rios‐Doria, et al.
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 2, pp. 217-226
Open Access | Times Cited: 26
Time trend of global uterine cancer burden: an age-period-cohort analysis from 1990 to 2019 and predictions in a 25-year period
Liu Yang, Yue Yuan, Rongyan Zhu, et al.
BMC Women s Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
An Overview of Endometrial Cancer with Novel Therapeutic Strategies
Theresa Kuhn, Saeeda Dhanani, Sarfraz Ahmad
Current Oncology (2023) Vol. 30, Iss. 9, pp. 7904-7919
Open Access | Times Cited: 25
The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
Sebastian Stępień, Paweł Olczyk, Joanna Gola, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1118-1118
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top